Publications

Marinkovic M, Stojanovic-Rundic S, Stanojevic A, Ostojic M, Gavrilovic D, Jankovic R, Maksimovic N, Stroggilos R, Zoidakis J, Castellví-Bel S, Fijneman RJA, and Cavic M. Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Front. Genet. 2023, 14:1245594. doi: 10.3389/fgene.2023.1245594. link: https://www.frontiersin.org/articles/10.3389/fgene.2023.1245594/full
2023 Marinkovic et al.

 

 

 

 

Marinkovic M, Stojanović-Rundic S, Djurić A, Stanojevic A, Gavrilovic D, Jankovic R, Zoidakis J, Castellvi-Bel S, Fijneman R, Cavic M. Is there a relation between hematological toxicity and response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer? 13th International Congress of the Serbian Society of Toxicology and 1st Toxsee Regional Conference: Present and Future of Toxicology: Challenges and Opportunities, 10-12 May, 2023 Belgrade, Serbia. Abstract book, p. 198-201. →

Djuric A, Tanic M, Bjelogrlic S, Stojanovic-Rundic S, Marinkovic M, Stanojevic A, Fijneman R, Castellví-Bel S, Zoidakis J, Cavic M. The Road from Human Sample Collections to the First Rectal Cancer Biobank at the Institute for Oncology and Radiology of Serbia. Molecular Oncology, Volume 17 (Suppl. 1):464-465. EACR 2023: Innovative Cancer Science, 12-15 June 2023, Torino, Italy. Abstract No. 0685.→

Stefanovic A, Lygirou V, Stojanovic-Rundic S, Jankovic R, Castellvi-Bel S, Fijneman R, Vlahou A, Zoidakis J, Samiotaki M, Cavic M. Correlation between genetic and proteomic expression of predictive biomarkers of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer identified by DIA mass spectrometry. Molecular Oncology, Volume 17 (Suppl. 1):96-97. EACR 2023: Innovative Cancer Science, 12-15 June 2023, Torino, Italy. Abstract No. 1195.→

Marinković M, Stojanović-Rundić S, Stefanović A, Janković R, Zoidakis J., Castellvi-Bel S., Fijneman R., Cavic M. Initial absolute basophil, eosinophil and monocyte counts as potential predictive markers in locally advanced rectal cancer. Annual meeting of the Hellenic Society of Biochemistry and Molecular Biology. 2-4.12.2022. Patra, Greece, Abstract book, ST56, P66. →

Stefanović A, Lygirou V, Marinković M, Stojanović-Rundić S, Janković R, Vlahou A, Zoidakis J, Fijneman R., Castellvi-Bel S., Samiotaki M, Čavić M. In-depth proteomic characterization of the response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using data-independent acquisition mass spectrometry (DIA-MS). Annual meeting of the Hellenic Society of Biochemistry and Molecular Biology. 2-4.12.2022. Patra, Greece, Abstract book, P3, P99. →

Marinković M, Stojanović-Rundić S, Stanojević A, Janković R, Zoidakis J, Castellvi-Bel S, J.A. Fijneman R, Čavić M, Radulovic M. Predicting response to chemoradiotherapy in locally advanced rectal cancer using MRI-based radiomics features. 6th Congress of Serbian Association for Cancer Research (SDIR): From Collaboration to Innovation in Cancer Research, October 02-04th 2023. Belgrade, Serbia. Oncology Insight ISSN 3009-3848 2023. 2023(1). Abstract book. p.59. →

Stanojević A, Samiotaki M, Lygirou V, Marinković M, Nikolić V, Stojanović-Rundić S, Janković R, Banko A, Miljanović D, Vlahou A, Panayotou G, J.A. Fijneman R, Castellvi-Bel S, Zoidakis J, Čavić M. Detection of viral proteins in locally advanced rectal cancer patient samples by mass spectrometry – predictive potential for response to neoadjuvant chemoradiotherapy. 6th Congress of Serbian Association for Cancer Research (SDIR): From Collaboration to Innovation in Cancer Research, October 02-04th 2023. Belgrade, Serbia. Oncology Insight ISSN 3009-3848 2023. 2023(1). Abstract book. p.77-78.→

Bjelogrlić S, Tanić M, Marinković M, Jelena Spasić S, Đurić S, Stojanović-Rundić S, Stanojević A, Đorđić Crnogorac M, Mirjačić Martinović K, Vuletić A, Damjanović Veličković A, Radulović M, Janković R, Zoidakis J, Fijneman R, Castellví-Bel S, Krivokuća A, Čavić M. Establishment of a first cancer Biobank at the Institute for Oncology and Radiology of Serbia –advantages, challenges and future perspective. 6th Congress of Serbian Association for Cancer Research (SDIR): From Collaboration to Innovation in Cancer Research, October 02-04th 2023. Belgrade, Serbia. Oncology Insight ISSN 3009-3848 2023. 2023(1). Abstract book. p.44-45.→

Djuric A, Tanic M, Bjelogrlic S, Marinkovic M, Stanojevic A, Spasic J, Stojanovic-Rundic S, Jankovic R, Krivokuca A, Mirjacic Martinovic K, Vuletic A, Djordjic Crnogorac M, Damjanovic A, Radulovic M, Fijneman R, Zoidakis J, Castellví-Bel S, Cavic M. Importance of Biobanks for Translational Cancer Research in Serbia. 73rd Panhellenic Conference of the Hellenic Society of Biochemistry and Molecular Biology 1 – 3 December, Athens, Greece. P200. Abstract book. p.300.→

 

Marinkovic M, Stojanovic-Rundic S, Stanojevic A, Ostojic M, Gavrilovic D, Jankovic R, Maksimovic N, Stroggilos R, Zoidakis J, Castellvi-Bel S, Fijneman R.J.A, Cavic M. Exploring novel inflammation-related genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. medRxiv 2023.06.20.23291673; doi: https://doi.org/10.1101/2023.06.20.23291673

Stanojevic A, Samiotaki M, Lygirou V, Marinkovic M, Nikolic V, Stojanovic-Rundic S, Jankovic R, Vlahou A, Panayotou G, Fijneman R.J.A, Castellvi-Bel S, Zoidakis J , Cavic M. Data independent acquisition mass spectrometry (DIA-MS) analysis of FFPE rectal cancer samples offers in depth proteomics characterization of response to neoadjuvant chemoradiotherapy. →

Stanojevic A, Spasic J, Marinkovic M, Stojanovic-Rundic S, Jankovic R, Djuric A, Zoidakis J, Fijneman R, Castellvi-Bel S, Cavic M. Methylenetetrahydrofolate reductase polymorphic variants in rectal cancer: significance for cancer risk and response to chemoradiotherapy. medRxiv 2023.09.21.23295916; doi: https://doi.org/10.1101/2023.09.21.23295916  →

Marinković M, Stojanović-Rundić S, Stanojevic A, Tomašević A, Janković R, Zoidakis J, Castellví-Bel S, Fijneman R, Čavić M, Radulović M. Performance and Dimensionality of Pretreatment MRI Radiomics in Rectal Carcinoma Chemoradiotherapy Prediction. Preprints 2023, 2023100560. https://doi.org/10.20944/preprints202310.0560.v1

 

Proteomics Dataset
Stanojevic A, Samiotaki M, Lygirou V, Marinkovic M, Nikolic V, Stojanovic-Rundic S, Jankovic R, Vlahou A, Panayotou G, Fijneman RJA, Castellví-Bel S, Zoidakis J, Cavic M. Data-Independent Acquisition Mass Spectrometry Analysis of FFPE Rectal Cancer Samples Offers In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy. Int J Mol Sci. 2023 24(20):1541.  DOI: 10.3390/ijms242015412, PubMed: 37895091.

 

Radiomics Dataset
Marko Radulovic, Mladen Marinkovic, & Milena Cavic. (2023). MRI Radiomics data of LARC patients who responded well and poorly to nCRT-Manuscript: Performance and Dimensionality of Pretreatment MRI Radiomics in Prediction of Rectal Carcinoma Response to Chemoradiotherapy. https://doi.org/10.5281/zenodo.8379940.
Marinkovic M, Stojanovic-Rundic S, Stanojevic A, Ostojic M, Gavrilovic D, Jankovic R, Maksimovic N, Stroggilos R, Zoidakis J, Castellví-Bel S, Fijneman RJA, and Cavic M. Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Front. Genet. 2023, 14:1245594. doi: 10.3389/fgene.2023.1245594. link: https://www.frontiersin.org/articles/10.3389/fgene.2023.1245594/full
2023 Marinkovic et al.

 

 

 

 

Marinkovic M, Stojanović-Rundic S, Djurić A, Stanojevic A, Gavrilovic D, Jankovic R, Zoidakis J, Castellvi-Bel S, Fijneman R, Cavic M. Is there a relation between hematological toxicity and response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer? 13th International Congress of the Serbian Society of Toxicology and 1st Toxsee Regional Conference: Present and Future of Toxicology: Challenges and Opportunities, 10-12 May, 2023 Belgrade, Serbia. Abstract book, p. 198-201. →

Djuric A, Tanic M, Bjelogrlic S, Stojanovic-Rundic S, Marinkovic M, Stanojevic A, Fijneman R, Castellví-Bel S, Zoidakis J, Cavic M. The Road from Human Sample Collections to the First Rectal Cancer Biobank at the Institute for Oncology and Radiology of Serbia. Molecular Oncology, Volume 17 (Suppl. 1):464-465. EACR 2023: Innovative Cancer Science, 12-15 June 2023, Torino, Italy. Abstract No. 0685.→

Stefanovic A, Lygirou V, Stojanovic-Rundic S, Jankovic R, Castellvi-Bel S, Fijneman R, Vlahou A, Zoidakis J, Samiotaki M, Cavic M. Correlation between genetic and proteomic expression of predictive biomarkers of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer identified by DIA mass spectrometry. Molecular Oncology, Volume 17 (Suppl. 1):96-97. EACR 2023: Innovative Cancer Science, 12-15 June 2023, Torino, Italy. Abstract No. 1195.→

Marinković M, Stojanović-Rundić S, Stefanović A, Janković R, Zoidakis J., Castellvi-Bel S., Fijneman R., Cavic M. Initial absolute basophil, eosinophil and monocyte counts as potential predictive markers in locally advanced rectal cancer. Annual meeting of the Hellenic Society of Biochemistry and Molecular Biology. 2-4.12.2022. Patra, Greece, Abstract book, ST56, P66. →

Stefanović A, Lygirou V, Marinković M, Stojanović-Rundić S, Janković R, Vlahou A, Zoidakis J, Fijneman R., Castellvi-Bel S., Samiotaki M, Čavić M. In-depth proteomic characterization of the response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using data-independent acquisition mass spectrometry (DIA-MS). Annual meeting of the Hellenic Society of Biochemistry and Molecular Biology. 2-4.12.2022. Patra, Greece, Abstract book, P3, P99. →

Marinković M, Stojanović-Rundić S, Stanojević A, Janković R, Zoidakis J, Castellvi-Bel S, J.A. Fijneman R, Čavić M, Radulovic M. Predicting response to chemoradiotherapy in locally advanced rectal cancer using MRI-based radiomics features. 6th Congress of Serbian Association for Cancer Research (SDIR): From Collaboration to Innovation in Cancer Research, October 02-04th 2023. Belgrade, Serbia. Oncology Insight ISSN 3009-3848 2023. 2023(1). Abstract book. p.59. →

Stanojević A, Samiotaki M, Lygirou V, Marinković M, Nikolić V, Stojanović-Rundić S, Janković R, Banko A, Miljanović D, Vlahou A, Panayotou G, J.A. Fijneman R, Castellvi-Bel S, Zoidakis J, Čavić M. Detection of viral proteins in locally advanced rectal cancer patient samples by mass spectrometry – predictive potential for response to neoadjuvant chemoradiotherapy. 6th Congress of Serbian Association for Cancer Research (SDIR): From Collaboration to Innovation in Cancer Research, October 02-04th 2023. Belgrade, Serbia. Oncology Insight ISSN 3009-3848 2023. 2023(1). Abstract book. p.77-78.→

Bjelogrlić S, Tanić M, Marinković M, Jelena Spasić S, Đurić S, Stojanović-Rundić S, Stanojević A, Đorđić Crnogorac M, Mirjačić Martinović K, Vuletić A, Damjanović Veličković A, Radulović M, Janković R, Zoidakis J, Fijneman R, Castellví-Bel S, Krivokuća A, Čavić M. Establishment of a first cancer Biobank at the Institute for Oncology and Radiology of Serbia –advantages, challenges and future perspective. 6th Congress of Serbian Association for Cancer Research (SDIR): From Collaboration to Innovation in Cancer Research, October 02-04th 2023. Belgrade, Serbia. Oncology Insight ISSN 3009-3848 2023. 2023(1). Abstract book. p.44-45.→

Djuric A, Tanic M, Bjelogrlic S, Marinkovic M, Stanojevic A, Spasic J, Stojanovic-Rundic S, Jankovic R, Krivokuca A, Mirjacic Martinovic K, Vuletic A, Djordjic Crnogorac M, Damjanovic A, Radulovic M, Fijneman R, Zoidakis J, Castellví-Bel S, Cavic M. Importance of Biobanks for Translational Cancer Research in Serbia. 73rd Panhellenic Conference of the Hellenic Society of Biochemistry and Molecular Biology 1 – 3 December, Athens, Greece. P200. Abstract book. p.300.→

Marinkovic M, Stojanovic-Rundic S, Stanojevic A, Ostojic M, Gavrilovic D, Jankovic R, Maksimovic N, Stroggilos R, Zoidakis J, Castellvi-Bel S, Fijneman R.J.A, Cavic M. Exploring novel inflammation-related genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. medRxiv 2023.06.20.23291673; doi: https://doi.org/10.1101/2023.06.20.23291673

Stanojevic A, Samiotaki M, Lygirou V, Marinkovic M, Nikolic V, Stojanovic-Rundic S, Jankovic R, Vlahou A, Panayotou G, Fijneman R.J.A, Castellvi-Bel S, Zoidakis J , Cavic M. Data independent acquisition mass spectrometry (DIA-MS) analysis of FFPE rectal cancer samples offers in depth proteomics characterization of response to neoadjuvant chemoradiotherapy. →

Stanojevic A, Spasic J, Marinkovic M, Stojanovic-Rundic S, Jankovic R, Djuric A, Zoidakis J, Fijneman R, Castellvi-Bel S, Cavic M. Methylenetetrahydrofolate reductase polymorphic variants in rectal cancer: significance for cancer risk and response to chemoradiotherapy. medRxiv 2023.09.21.23295916; doi: https://doi.org/10.1101/2023.09.21.23295916  →

Marinković M, Stojanović-Rundić S, Stanojevic A, Tomašević A, Janković R, Zoidakis J, Castellví-Bel S, Fijneman R, Čavić M, Radulović M. Performance and Dimensionality of Pretreatment MRI Radiomics in Rectal Carcinoma Chemoradiotherapy Prediction. Preprints 2023, 2023100560. https://doi.org/10.20944/preprints202310.0560.v1

 

Proteomics Dataset
Stanojevic A, Samiotaki M, Lygirou V, Marinkovic M, Nikolic V, Stojanovic-Rundic S, Jankovic R, Vlahou A, Panayotou G, Fijneman RJA, Castellví-Bel S, Zoidakis J, Cavic M. Data-Independent Acquisition Mass Spectrometry Analysis of FFPE Rectal Cancer Samples Offers In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy. Int J Mol Sci. 2023 24(20):1541.  DOI: 10.3390/ijms242015412, PubMed: 37895091.

 

Radiomics Dataset
Marko Radulovic, Mladen Marinkovic, & Milena Cavic. (2023). MRI Radiomics data of LARC patients who responded well and poorly to nCRT-Manuscript: Performance and Dimensionality of Pretreatment MRI Radiomics in Prediction of Rectal Carcinoma Response to Chemoradiotherapy. https://doi.org/10.5281/zenodo.8379940.

Latest News & Events